These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
6. Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models. Bartlett DE; Miller RB; Thiesfeldt S; Lakhani HV; Khanal T; D Pratt R; Cottrill CL; Klug RL; Adkins NS; Bown PC; Nease DB; Shapiro JI; Sodhi K Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201874 [TBL] [Abstract][Full Text] [Related]
7. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327 [TBL] [Abstract][Full Text] [Related]
8. Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species' Release. Adesso S; Ruocco M; Rapa SF; Piaz FD; Raffaele Di Iorio B; Popolo A; Autore G; Nishijima F; Pinto A; Marzocco S Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31072046 [TBL] [Abstract][Full Text] [Related]
9. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716 [TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway. Masai N; Tatebe J; Yoshino G; Morita T Circ J; 2010 Oct; 74(10):2216-24. PubMed ID: 20818133 [TBL] [Abstract][Full Text] [Related]
11. Advanced oxidation protein products induce inflammatory response and insulin resistance in cultured adipocytes via induction of endoplasmic reticulum stress. Zhou QG; Zhou M; Lou AJ; Xie D; Hou FF Cell Physiol Biochem; 2010; 26(4-5):775-86. PubMed ID: 21063115 [TBL] [Abstract][Full Text] [Related]
12. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120. Liu WC; Tomino Y; Lu KC Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of indoxyl sulfate, a uremic toxin, on the intracellular oxidation level and phagocytic activity using an HL-60-differentiated human macrophage cell model. Tsutsumi S; Tokunaga Y; Shimizu S; Kinoshita H; Ono M; Kurogi K; Sakakibara Y; Suiko M; Liu MC; Yasuda S Biosci Biotechnol Biochem; 2020 May; 84(5):1023-1029. PubMed ID: 31942834 [TBL] [Abstract][Full Text] [Related]
14. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Watanabe H; Miyamoto Y; Honda D; Tanaka H; Wu Q; Endo M; Noguchi T; Kadowaki D; Ishima Y; Kotani S; Nakajima M; Kataoka K; Kim-Mitsuyama S; Tanaka M; Fukagawa M; Otagiri M; Maruyama T Kidney Int; 2013 Apr; 83(4):582-92. PubMed ID: 23325087 [TBL] [Abstract][Full Text] [Related]
15. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306 [TBL] [Abstract][Full Text] [Related]
16. Indoxyl sulfate is a nephro-vascular toxin. Niwa T J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565 [TBL] [Abstract][Full Text] [Related]
17. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Palm F; Nangaku M; Fasching A; Tanaka T; Nordquist L; Hansell P; Kawakami T; Nishijima F; Fujita T Am J Physiol Renal Physiol; 2010 Aug; 299(2):F380-6. PubMed ID: 20519374 [TBL] [Abstract][Full Text] [Related]
18. Modulation of NADPH oxidase activity by known uraemic retention solutes. Schulz AM; Terne C; Jankowski V; Cohen G; Schaefer M; Boehringer F; Tepel M; Kunkel D; Zidek W; Jankowski J; Eur J Clin Invest; 2014 Aug; 44(8):802-11. PubMed ID: 25041433 [TBL] [Abstract][Full Text] [Related]
19. Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways. Dias GF; Bonan NB; Steiner TM; Tozoni SS; Rodrigues S; Nakao LS; Kuntsevich V; Pecoits Filho R; Kotanko P; Moreno-Amaral AN Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29976888 [TBL] [Abstract][Full Text] [Related]
20. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway? Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]